Vascular graft thrombosis occurs when a blood clot forms and blocks a surgically placed blood vessel replacement, leading to graft failure and potentially serious complications. Understanding when and how this condition is diagnosed can help ensure timely treatment and better outcomes for patients.

Introduction: Who Should Undergo Diagnostics

Patients who have undergone vascular graft surgery should be closely monitored for signs that might indicate graft thrombosis. A vascular graft is an artificial tube or a reprocessed blood vessel used to replace or bypass diseased or blocked arteries. These grafts are commonly used for hemodialysis access, cardiovascular bypass procedures, and limb blood vessel replacement. The success or failure of these reconstructions often depends on early detection of problems that could lead to clot formation^[1].

Anyone who has received a vascular graft needs to understand when diagnostic evaluation is necessary. If you notice changes in your graft, such as loss of the normal vibration or pulsation you usually feel, this warrants immediate attention. For patients with arteriovenous grafts used for dialysis, the “look, feel, and listen” approach is particularly important. You should regularly check your graft by feeling for the characteristic thrill—a vibrating sensation created by blood flowing through the graft. If this sensation weakens, disappears, or becomes excessively strong and pulsatile, it could signal a problem^[12].

Additional warning signs include redness, swelling, or warmth around the graft site, which might indicate infection. Pain or coolness in the limb containing the graft could suggest reduced blood flow. For patients with grafts in their legs or arms, any changes in skin color, temperature, or sensation should prompt immediate medical evaluation. In general, any sudden change in how your graft looks, feels, or functions is reason enough to seek diagnostic testing^[12].

The timing of diagnostic evaluation matters greatly. Early graft thrombosis—occurring within one to thirty days after surgery—typically results from technical errors during the surgical procedure, while intermediate failures happening between thirty days and two years often stem from tissue overgrowth. Late failures, occurring after two years, usually relate to disease progression in the blood vessels. Understanding this timeline helps doctors determine which diagnostic tests will be most helpful^[5][10].

Classic Diagnostic Methods

The diagnostic process for vascular graft thrombosis begins with simple physical examination techniques that patients and doctors can perform at any time. The most basic assessment involves checking for the presence or absence of blood flow through the graft. For arteriovenous grafts used in dialysis patients, healthcare providers and patients themselves can feel for a thrill—a vibrating sensation caused by turbulent blood flow. This thrill should be present throughout the length of the graft. If the thrill is absent or significantly changed, it strongly suggests thrombosis or another problem affecting blood flow^[12].

Listening to the graft with a stethoscope reveals a characteristic whooshing sound called a bruit. Changes in the pitch or quality of this sound can indicate problems. A high-pitched bruit or one that lacks its normal continuous quality might suggest narrowing somewhere in the graft or its connecting vessels. Doctors also assess the pulsatility of the graft—increased pulsation can indicate blockage in the outflow vein, while decreased pulsation might point to problems with blood flow entering the graft^[12].

The arm elevation test provides valuable information about potential blockages without requiring any equipment. During this test, the arm containing the graft is held above the level of the heart. Normally, the graft should collapse somewhat as blood drains out. However, if there is a narrowing or stenosis—an abnormal narrowing of the blood vessel—the graft will collapse only up to the point of the blockage. The portion beyond the blockage remains filled because blood cannot flow through the narrowed area. This simple test helps doctors locate where problems might exist along the graft^[12].

When physical examination suggests problems, ultrasound imaging becomes the next diagnostic step. Ultrasound uses sound waves to create pictures of the graft and surrounding blood vessels. This test is painless and carries no radiation exposure. A specialized form called Doppler ultrasound not only shows the structure of the graft but also measures blood flow speed and direction. This helps doctors identify areas of narrowing, detect blood clots, and assess how well blood is moving through the graft. While routine ultrasound screening of healthy, functioning grafts is not standard practice, using ultrasound to investigate specific symptoms or signs of dysfunction can provide important benefits^[12].

When ultrasound findings are unclear or when more detailed information is needed, doctors may order angiography. This procedure involves injecting a contrast dye that shows up on X-ray images, creating detailed pictures of blood flow through the graft and surrounding vessels. Angiography can precisely identify the location and severity of blockages, detect blood clots, and reveal areas of tissue overgrowth that might be compromising graft function. The procedure is typically performed by inserting a small catheter directly into the graft or through another blood vessel. A technique called pullback angiography, where the catheter is slowly withdrawn while images are taken, helps doctors see the entire length of the graft and identify exactly where problems exist^[4][8].

The timing of diagnostic evaluation significantly affects success rates for treatment. For thrombosed grafts, there is generally no medical urgency to perform testing within the first two to three days after the clot forms. Success rates for clearing the clot remain similar whether the procedure happens immediately or within forty-eight to seventy-two hours. However, waiting longer than a week begins to reduce success rates. After one to two weeks, success rates may drop from the high nineties to the mid-eighties percent range. This decline occurs because blood clots become more firmly attached to vessel walls over time, making them harder to remove^[2][6].

Distinguishing between fresh and old clots matters for treatment planning. Fresh clots, typically present within a few days of formation, are easier to treat and remove. Old clots that have been present for weeks or longer adhere more firmly to the graft walls and may require different treatment approaches. Doctors can often determine clot age through a combination of patient history, physical findings, and imaging characteristics seen on ultrasound or angiography^[2][6].

During diagnostic angiography, doctors always look for specific features that commonly accompany graft thrombosis. One universal finding in thrombosed arteriovenous grafts is the presence of an arterial plug—a clot that forms at the connection point where the graft meets the artery. This plug is present one hundred percent of the time in graft thrombosis. Some physicians may mistakenly interpret the appearance of this plug as a narrowing of the artery itself, but recognizing it as a clot rather than structural narrowing is crucial for proper treatment^[2][6].

Diagnostic procedures must also identify the underlying cause of thrombosis to prevent recurrence. The most common cause of arteriovenous graft thrombosis is tissue overgrowth at the point where the graft connects to a vein, or in the vein that carries blood away from the graft. This condition, called intimal hyperplasia, involves abnormal growth and thickening of the vessel’s inner lining. When blood vessels are injured, cells from the vessel wall can migrate inward and multiply, gradually narrowing the vessel opening. This process typically develops over months to years. Identifying these narrowed areas during diagnostic testing allows doctors to address them during treatment, reducing the likelihood that the graft will clot again^[2][6][10].

Diagnostics for Clinical Trial Qualification

Clinical trials testing new treatments for vascular graft thrombosis require standardized diagnostic methods to ensure all enrolled patients have similar conditions that can be accurately measured and compared. The specific diagnostic tests used vary depending on the trial design and the intervention being studied, but certain common assessments are nearly universal.

Imaging confirmation of graft thrombosis is typically required before patients can enroll in clinical trials. Most trials use angiography as the gold standard for documenting the presence, location, and extent of blood clots within the graft. This provides objective, reproducible evidence of thrombosis that can be reviewed by multiple physicians and compared before and after treatment. Angiography also allows measurement of features like the length of the clot, the degree of vessel narrowing at various points, and the quality of blood flow in vessels leading to and away from the graft^[4][8].

Ultrasound measurements often supplement angiography in clinical trials. Doppler ultrasound can measure blood flow velocities and patterns, providing quantitative data about graft function. These measurements can be repeated over time without exposing patients to radiation or invasive procedures, making ultrasound valuable for monitoring treatment response during follow-up periods.

Clinical trials typically establish specific time windows for when thrombosis occurred relative to when patients can enroll. For example, some trials may only include patients whose grafts thrombosed within the previous two weeks, ensuring that all participants have relatively fresh clots that respond similarly to treatment. Other trials might specifically seek patients with older, more adherent clots to test interventions designed for difficult cases^[2][6].

Documentation of previous graft history and interventions forms another standard requirement. Trials need to know whether the thrombosed graft is experiencing its first clotting event or represents a recurrent problem. They often record how many previous interventions the graft has undergone, what treatments were tried, and how long the graft remained functional after each intervention. This information helps researchers understand whether new treatments work better for first-time thrombosis versus repeat occurrences^[4][8].

Blood tests to assess clotting function and identify hypercoagulable states—conditions that make blood clot too easily—may be required for trial enrollment. These tests help researchers understand whether thrombosis resulted primarily from mechanical problems with the graft or from underlying blood disorders that promote clotting. Patients with certain genetic conditions that increase clotting risk might be excluded from some trials or analyzed as a separate subgroup^[10].

Assessment of the anatomic quality of blood vessels connected to the graft is important for trial qualification. Researchers need to verify that the artery supplying blood to the graft and the vein draining blood from it are adequate. Poor inflow from the artery or inadequate outflow through the vein can cause graft failure regardless of the intervention being tested. Trials typically exclude patients whose vessel anatomy makes graft failure likely for reasons unrelated to the treatment under investigation^[10].

Measurement of graft patency—whether the graft remains open and functional—serves as the primary outcome measure in most clinical trials. Diagnostic criteria for patency must be clearly defined and consistently applied. Some trials define patency as the ability to perform dialysis treatment successfully, while others use more technical measures like specific blood flow rates through the graft or absence of any clot on imaging studies.